Cost-effectiveness of Ivabradine as a Treatment for Systolic Chronic Heart Failure in the United States

被引：0
|
作者：
Kansal, Anuraag R.
Cowie, Martin
Kielhorn, Adrian
Krotneva, Stanimira
Taffazzoli, Ali
Zheng, Ying
Yurgin, Nicole
机构：
来源：
CIRCULATION | 2015年 / 132卷
关键词：
cost effectiveness; systolic chronic heart failure; ivabradine; quality-adjusted life years; hospitalization;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
17655
引用
下载
收藏
页数：4
相关论文
共 50 条
  • [31] Cost-Effectiveness of Quadruple Therapy in Management of Heart Failure With Reduced Ejection Fraction in the United States
    Yan, Brandon W. W.
    Spahillari, Aferdita
    Pandya, Ankur
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2023, 16 (06): : 401 - 410
  • [32] A COST-EFFECTIVENESS ANALYSIS OF CORALAN® (IVABRADINE) PLUS STANDARD CARE VERSUS STANDARD CARE ALONE IN CHRONIC HEART FAILURE
    Ergene, O.
    Oto, A.
    Cavusoglu, Y.
    Aydogdu, S.
    Ozdemir, O.
    Tan, M.
    VALUE IN HEALTH, 2012, 15 (07) : A372 - A372
  • [33] Cost-Effectiveness Of Riociguat For The Treatment Of Chronic Thromboembolic Pulmonary Hypertension (cteph) In The United States
    Kadambi, A.
    Chapman, R.
    Quon, P.
    Brand, S.
    Sikirica, M.
    Joish, V. N.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [34] Cost-Effectiveness Analysis of Ofatumumab As a Treatment for Relapsed Chronic Lymphocytic Leukemia in the United States
    Tremblay, Gabriel
    Forsythe, Anna
    Bal, Vasudha
    Santra, Snigdha
    Briggs, Andrew
    BLOOD, 2016, 128 (22)
  • [35] COST-EFFECTIVENESS OF DAPAGLIFLOZIN FOR THE TREATMENT OF HEART FAILURE WITH REDUCED EJECTION FRACTION: ANALYSES FROM THE PERSPECTIVES OF FRANCE AND THE UNITED STATES
    Binnie, R.
    Omar, Alsaleh Aj
    VALUE IN HEALTH, 2022, 25 (01) : S60 - S60
  • [36] Cost-effectiveness of candesartan in Germany for patients with chronic heart failure
    Voelkl, M
    Pirk, O
    Juenger, V
    VALUE IN HEALTH, 2005, 8 (06) : A96 - A96
  • [37] Long-Term Cost-Effectiveness of Disease Management in Systolic Heart Failure
    Miller, George
    Randolph, Stephen
    Forkner, Emma
    Smith, Brad
    Galbreath, Autumn Dawn
    MEDICAL DECISION MAKING, 2009, 29 (03) : 325 - 333
  • [38] A Cost-effectiveness Analysis of Ventricular Assist Devices (VAD) for the Treatment of Systolic Heart Failure in Pediatric Patients
    Priromprintr, Bryant
    Song, Nancy
    Owens, Douglas K.
    Salomon, Joshua
    Cho, Seo-Ho
    Ton, Sony
    Zhao, Diana Y.
    Almond, Christopher S.
    Rosenthal, David N.
    Goldhaber-Fibert, Jeremy D.
    Shin, Andrew
    CIRCULATION, 2019, 140
  • [39] COST-EFFECTIVENESS ANALYSIS OF IVABRADINE IN HEART FAILURE WITH REDUCED LEFT VENTRICULAR EJECTION FRACTION IN SPAIN
    Fernandez de Bobadilla, J.
    Gonzalez Fernandez, O.
    Lopez de Sa, E.
    Lopez-Sendon, J. L.
    VALUE IN HEALTH, 2014, 17 (07) : A486 - A486
  • [40] Cost-effectiveness of vibegron for the treatment of overactive bladder in the United States
    Chen, Jing Voon
    Klein, Timothy M.
    Nesheim, Jeffrey
    Mudd, Paul N., Jr.
    JOURNAL OF MEDICAL ECONOMICS, 2022, 25 (01) : 1092 - 1100
12345